Soquelitinib (CPI-818) is an experimental drug which acts as a selective inhibitor of the enzyme interleukin-2-inducible T-cell kinase (ITK). It is in clinical trials for the treatment of T-cell lymphoma.
References
Wikipedia
Soquelitinib
Tags
- Carboxamides
- Cyclopropyl compounds
- Diazepanes
- Experimental drugs
- Methoxy compounds
- Thiazoles
- Thioethers